Literature DB >> 17229569

Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D.

Alina Porojnicu1, Trude Eid Robsahm, Jens Petter Berg, Johan Moan.   

Abstract

The calcidiol level in a group of Norwegians (14,000 individuals, age range 16-80) was found to be highest in late summer. The seasonal variation was larger for young than for old persons. The calcitriol concentration was practically constant throughout the year. Younger persons had less calcidiol and more calcitriol than older persons, indicating that the conversion of calcidiol to calcitriol is more efficient in younger persons. A seasonal variation of prognosis of cancer (colon-, breast-, prostate- cancer and Hodgkin lymphoma) was found. The survival is highest for summer and autumn diagnosis, corresponding to maximal calcidiol levels. Thus, calcidiol may act synergistically with traditional treatment modalities. In view of these calcitriol and calcidiol data, the seasonal variation of cancer survival may be related to the calcidiol gradient, indicating that this Vitamin D metabolite may be more important than believed so far.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229569     DOI: 10.1016/j.jsbmb.2006.12.031

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  22 in total

1.  Similarities in solar ultraviolet irradiance and other environmental factors may explain much of the family link between uveal melanoma and other cancers.

Authors:  William B Grant; Johan E Moan; Emanuela Micu; Alina C Porojnicu; Asta Juzeniene
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

2.  Duration of vitamin D synthesis from weather model data for use in prospective epidemiological studies.

Authors:  Kåre Edvardsen; Ola Engelsen; Magritt Brustad
Journal:  Int J Biometeorol       Date:  2009-05-15       Impact factor: 3.787

3.  Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-01

4.  Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer.

Authors:  Pankaj G Vashi; Carolyn A Lammersfeld; Donald P Braun; Digant Gupta
Journal:  Nutr J       Date:  2011-05-16       Impact factor: 3.271

Review 5.  Vitamin D and cardiovascular disease and cancer: not too much and not too little? The need for clinical trials.

Authors:  Michal L Melamed; JoAnn E Manson
Journal:  Womens Health (Lond)       Date:  2011-07

Review 6.  Vitamin D and skin cancer.

Authors:  Erin M Burns; Craig A Elmets; Nabiha Yusuf
Journal:  Photochem Photobiol       Date:  2014-12-08       Impact factor: 3.421

Review 7.  Vitamin D and breast cancer.

Authors:  Theresa Shao; Paula Klein; Michael L Grossbard
Journal:  Oncologist       Date:  2012-01-10

Review 8.  Role of vitamin and mineral supplementation and aspirin use in cancer survivors.

Authors:  Edward Giovannucci; Andrew T Chan
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

9.  High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy.

Authors:  Katherine D Crew; Elizabeth Shane; Serge Cremers; Donald J McMahon; Dinaz Irani; Dawn L Hershman
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

10.  Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer.

Authors:  Rebecca Suk Heist; Wei Zhou; Zhaoxi Wang; Geoffrey Liu; Donna Neuberg; Li Su; Kofi Asomaning; Bruce W Hollis; Thomas J Lynch; John C Wain; Edward Giovannucci; David C Christiani
Journal:  J Clin Oncol       Date:  2008-10-20       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.